Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2022

    2022 World Conference on Lung Cancer

    Conference Program for 2022 the World Conference on Lung Cancer

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2015

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    WS02 - IASLC CT Screening Symposium: Forefront Advances in Lung Cancer Screening (Ticketed Session) (In-person Access Only)

    • Type: Workshop
    • Track: N/A
    • Presentations: 44
    • Moderators:Chunxue Bai
    • Coordinates: 8/05/2022, 09:00 - 16:00, Strauss 3
    • +

      WS02.19 - Quality Assurance of Radiology Reporting: PERFECTS

      11:05 - 11:15  |  Author(s): Yan Chen

      • Abstract

      Loading...

  • +

    EP08.01 - Metastatic Non-small Cell Lung Cancer - Immunotherapy

    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • Presentations: 108
    • Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
    • +

      EP08.01-032 - Sintilimab in Combination with Anlotinib in NSCLC Patients with Uncommon EGFR Mutations: A Phase II, Single-arm, Prospective Study

      Author(s): Yun Fan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • Presentations: 172
    • Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
    • +

      EP08.02-064 - ASTRIS China: A Real-world Study of Osimertinib in Patients with EGFR T790M Positive Non-small-cell Lung Cancer (NSCLC)

      Author(s): Qing Zhou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      EP08.02-139 - A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs

      Author(s): Shun Lu

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA02 - From Locally Advanced to Unresectable NSCLC: Improvement of Multimodality Treatment

    • Type: Oral
    • Track: Locally Advanced Non-small Cell Lung Cancer
    • Presentations: 9
    • Moderators:Isabelle Opitz
    • Coordinates: 8/07/2022, 12:00 - 13:00, Hall C7
    • +

      OA02.05 - Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study

      12:22 - 12:32  |  Author(s): Yi-Long Wu

      • Abstract

      Loading...